{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:41:14Z","timestamp":1740138074420,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12010-022-04237-4","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T07:03:12Z","timestamp":1669186992000},"page":"2077-2092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delivery of Fc-fusion Protein by a Recombinant Newcastle Disease Virus Vector"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8102-595X","authenticated-orcid":false,"given":"Zenglei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"15s","key":"4237_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/fon-2017-0157","volume":"13","author":"B Coiffier","year":"2017","unstructured":"Coiffier, B. (2017). Preparing for a new generation of biologic therapies: Understanding the development and potential of biosimilar cancer therapeutics. Future Oncology, 13(15s), 1\u20133.","journal-title":"Future Oncology"},{"issue":"6","key":"4237_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40265-017-0717-1","volume":"77","author":"P Declerck","year":"2017","unstructured":"Declerck, P., Danesi, R., Petersel, D., & Jacobs, I. (2017). The language of biosimilars: Clarification, definitions, and regulatory aspects. Drugs, 77(6), 671\u2013677.","journal-title":"Drugs"},{"issue":"4","key":"4237_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/00325481.2017.1311196","volume":"129","author":"DM Geynisman","year":"2017","unstructured":"Geynisman, D. M., De Velasco, G., Sewell, K. L., & Jacobs, I. (2017). Biosimilar biologic drugs: A new frontier in medical care. Postgraduate Medicine, 129(4), 460\u2013470.","journal-title":"Postgraduate Medicine"},{"issue":"10","key":"4237_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/emmm.201201379","volume":"4","author":"DM Czajkowsky","year":"2012","unstructured":"Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012). Fc-fusion proteins: New developments and future perspectives. EMBO Molecular Medicine, 4(10), 1015\u20131028.","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"4237_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/07388551.2016.1163323","volume":"37","author":"S Soleimanpour","year":"2017","unstructured":"Soleimanpour, S., Hassannia, T., Motiee, M., Amini, A. A., & Rezaee, S. A. R. (2017). Fc1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: Immunological, biochemical and therapeutic properties. Critical Reviews in Biotechnology, 37(3), 371\u2013392.","journal-title":"Critical Reviews in Biotechnology"},{"issue":"9","key":"4237_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian, D. C., & Akilesh, S. (2007). FcRn: The neonatal Fc receptor comes of age. Nature Reviews. Immunology, 7(9), 715\u2013725.","journal-title":"Nature Reviews. Immunology"},{"issue":"4","key":"4237_CR7","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.4049\/jimmunol.0903296","volume":"184","author":"T Suzuki","year":"2010","unstructured":"Suzuki, T., Ishii-Watabe, A., Tada, M., Kobayashi, T., Kanayasu-Toyoda, T., Kawanishi, T., & Yamaguchi, T. (2010). Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: A comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. Journal of Immunology, 184(4), 1968\u20131976.","journal-title":"Journal of Immunology"},{"issue":"2","key":"4237_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nbt.1742","volume":"29","author":"L Ye","year":"2011","unstructured":"Ye, L., Zeng, R., Bai, Y., Roopenian, D. C., & Zhu, X. (2011). Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nature Biotechnology, 29(2), 158\u2013163.","journal-title":"Nature Biotechnology"},{"key":"4237_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.omto.2021.09.005","volume":"23","author":"M Billerhart","year":"2021","unstructured":"Billerhart, M., Schonhofer, M., Schueffl, H., Polzer, W., Pichler, J., Decker, S., Taschauer, A., Maier, J., Anton, M., Eckmann, S., Blaschek, M., Heffeter, P., Sami, H., & Ogris, M. (2021). CD47-targeted cancer immunogene therapy: Secreted SIRPa-Fc fusion protein eradicates tumors by macrophage and NK cell activation. Molecular Therapy-Oncolytics, 23, 192\u2013204.","journal-title":"Molecular Therapy-Oncolytics"},{"issue":"1","key":"4237_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","volume":"33","author":"D Levin","year":"2015","unstructured":"Levin, D., Golding, B., Strome, S. E., & Sauna, Z. E. (2015). Fc fusion as a platform technology: Potential for modulating immunogenicity. Trends in Biotechnology, 33(1), 27\u201334.","journal-title":"Trends in Biotechnology"},{"issue":"1","key":"4237_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.vaccine.2011.10.056","volume":"30","author":"GJ Zaharatos","year":"2011","unstructured":"Zaharatos, G. J., Yu, J., Pace, C., Song, Y., Vasan, S., Ho, D. D., & Huang, Y. X. (2011). HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice. Vaccine, 30(1), 42\u201350.","journal-title":"Vaccine"},{"key":"4237_CR12","doi-asserted-by":"publisher","first-page":"717326","DOI":"10.3389\/fbioe.2021.717326","volume":"9","author":"C Sanchez-Trasvina","year":"2021","unstructured":"Sanchez-Trasvina, C., Flores-Gatica, M., Enriquez-Ochoa, D., Rito-Palomares, M., & Mayolo-Deloisa, K. (2021). Purification of modified therapeutic proteins available on the market: An analysis of chromatography-based strategies. Frontiers in Bioengineering and Biotechnology, 9, 717326.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"4237_CR13","doi-asserted-by":"publisher","first-page":"100506","DOI":"10.1016\/j.lanwpc.2022.100506","volume":"26","author":"X Tong","year":"2022","unstructured":"Tong, X., Li, X., Pratt, N. L., Hillen, J. B., Stanford, T., Ward, M., Roughead, E. E., Lai, E. C., Shin, J. Y., Cheng, F. W. T., Peng, K., Lau, C. S., Leung, W. K., & Wong, I. C. K. (2022). Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020. The Lancet Regional Health Western Pacific, 26, 100506.","journal-title":"The Lancet Regional Health Western Pacific"},{"issue":"5","key":"4237_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/v14050975","volume":"14","author":"JPC Fulber","year":"2022","unstructured":"Fulber, J. P. C., & Kamen, A. A. (2022). Development and scalable production of Newcastle disease virus-vectored vaccines for human and veterinary use. Viruses, 14(5), 975.","journal-title":"Viruses"},{"issue":"2","key":"4237_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/vaccines8020222","volume":"8","author":"Z Hu","year":"2020","unstructured":"Hu, Z., Ni, J., Cao, Y., & Liu, X. (2020). Newcastle disease virus as a vaccine vector for 20 years: A focus on maternally derived antibody interference. Vaccines, 8(2), 222.","journal-title":"Vaccines"},{"issue":"7","key":"4237_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v8070183","volume":"8","author":"SH Kim","year":"2016","unstructured":"Kim, S. H., & Samal, S. K. (2016). Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses, 8(7), 183.","journal-title":"Viruses"},{"issue":"3","key":"4237_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/glycob\/cwr146","volume":"22","author":"Q Sun","year":"2012","unstructured":"Sun, Q., Zhao, L., Song, Q., Wang, Z., Qiu, X., Zhang, W., Zhao, M., Zhao, G., Liu, W., Liu, H., & Liu, X. (2012). Hybrid- and complex-type N-glycans are not essential for Newcastle disease virus infection and fusion of host cells. Glycobiology, 22(3), 369\u2013378.","journal-title":"Glycobiology"},{"issue":"14","key":"4237_CR18","first-page":"14","volume":"40","author":"Z Hu","year":"2018","unstructured":"Hu, Z., Liu, X., Hu, J., Gu, H., Shi, L., Li, R., Gan, J., Jiao, X., & Liu, X. (2018). Comparison of immunogenicity of Newcastle disease virus-vectored vaccines expressing secreted and membrane-associated hemagglutinin from H7N9 subtype avian influenza virus. China Poultry, 40(14), 14\u201318.","journal-title":"China Poultry"},{"issue":"6","key":"4237_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.vaccine.2008.11.091","volume":"27","author":"S Hu","year":"2009","unstructured":"Hu, S., Ma, H., Wu, Y., Liu, W., Wang, X., Liu, Y., & Liu, X. (2009). A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine, 27(6), 904\u2013910.","journal-title":"Vaccine"},{"issue":"3","key":"4237_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1637\/9633-122410-Reg.1","volume":"55","author":"Z Hu","year":"2011","unstructured":"Hu, Z., Hu, S., Meng, C., Wang, X., Zhu, J., & Liu, X. (2011). Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs. Avian Diseases, 55(3), 391\u2013397.","journal-title":"Avian Diseases"},{"issue":"11","key":"4237_CR21","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1128\/JVI.02696-10","volume":"85","author":"M Subbiah","year":"2011","unstructured":"Subbiah, M., Khattar, S. K., Collins, P. L., & Samal, S. K. (2011). Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. Journal of Virology, 85(11), 5394\u20135405.","journal-title":"Journal of Virology"},{"issue":"48 Pt B","key":"4237_CR22","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1016\/j.vaccine.2017.10.010","volume":"35","author":"Z Hu","year":"2017","unstructured":"Hu, Z., Liu, X., & Jiao, X. (2017). Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges. Vaccine, 35(48 Pt B), 6585\u20136590.","journal-title":"Vaccine"},{"key":"4237_CR23","doi-asserted-by":"publisher","first-page":"106151","DOI":"10.1016\/j.pep.2022.106151","volume":"200","author":"MM Thu","year":"2022","unstructured":"Thu, M. M., Takheaw, N., Laopajon, W., & Pata, S. (2022). Optimization of culture conditions for stable expression of recombinant fc-fused human extracellular CD99 in HEK293T cells. Protein Expression and Purification, 200, 106151.","journal-title":"Protein Expression and Purification"},{"issue":"9","key":"4237_CR24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1248\/bpb.b22-00247","volume":"45","author":"KI Ishibashi","year":"2022","unstructured":"Ishibashi, K. I., Onaka, N., Nishida, N., Takahashi, M., Adachi, Y., & Ohno, N. (2022). Dectin-1 Reactivity to paramylon derived from Euglena gracilis EOD-1. Biological & Pharmaceutical Bulletin, 45(9), 1394\u20131397.","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"4237_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1297-9716-42-38","volume":"42","author":"AS Samuel","year":"2011","unstructured":"Samuel, A. S., Subbiah, M., Shive, H., Collins, P. L., & Samal, S. K. (2011). Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9. Veterinary Research, 42, 38.","journal-title":"Veterinary Research"},{"issue":"14","key":"4237_CR26","doi-asserted-by":"publisher","first-page":"8235","DOI":"10.1128\/JVI.01085-13","volume":"87","author":"PH Goff","year":"2013","unstructured":"Goff, P. H., Krammer, F., Hai, R., Seibert, C. W., Margine, I., Garcia-Sastre, A., & Palese, P. (2013). Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. Journal of Virology, 87(14), 8235\u20138240.","journal-title":"Journal of Virology"},{"issue":"2","key":"4237_CR27","doi-asserted-by":"publisher","first-page":"e0118626","DOI":"10.1371\/journal.pone.0118626","volume":"10","author":"D Cao","year":"2015","unstructured":"Cao, D., Wu, H., Li, Q., Sun, Y., Liu, T., Fei, J., Zhao, Y., Wu, S., Hu, X., & Li, N. (2015). Expression of recombinant human lysozyme in egg whites of transgenic hens. PLoS ONE, 10(2), e0118626.","journal-title":"PLoS ONE"},{"issue":"17","key":"4237_CR28","doi-asserted-by":"publisher","first-page":"10864","DOI":"10.1128\/JVI.79.17.10864-10874.2005","volume":"79","author":"M Kamihira","year":"2005","unstructured":"Kamihira, M., Ono, K., Esaka, K., Nishijima, K., Kigaku, R., Komatsu, H., Yamashita, T., Kyogoku, K., & Iijima, S. (2005). High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector. Journal of Virology, 79(17), 10864\u201310874.","journal-title":"Journal of Virology"},{"issue":"7","key":"4237_CR29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/mrd.20860","volume":"75","author":"MS Kwon","year":"2008","unstructured":"Kwon, M. S., Koo, B. C., Choi, B. R., Park, Y. Y., Lee, Y. M., Suh, H. S., Park, Y. S., Lee, H. T., Kim, J. H., Roh, J. Y., Kim, N. H., & Kim, T. (2008). Generation of transgenic chickens that produce bioactive human granulocyte-colony stimulating factor. Molecular Reproduction and Development, 75(7), 1120\u20131126.","journal-title":"Molecular Reproduction and Development"},{"issue":"9","key":"4237_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt1132","volume":"23","author":"L Zhu","year":"2005","unstructured":"Zhu, L., van de Lavoir, M. C., Albanese, J., Beenhouwer, D. O., Cardarelli, P. M., Cuison, S., Deng, D. F., Deshpande, S., Diamond, J. H., Green, L., Halk, E. L., Heyer, B. S., Kay, R. M., Kerchner, A., Leighton, P. A., Mather, C. M., Morrison, S. L., Nikolov, Z. L., Passmore, D. B., \u2026 Etches, R. J. (2005). Production of human monoclonal antibody in eggs of chimeric chickens. Nature Biotechnology, 23(9), 1159\u20131169.","journal-title":"Nature Biotechnology"},{"issue":"1","key":"4237_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pep.2009.01.003","volume":"65","author":"IL Tutykhina","year":"2009","unstructured":"Tutykhina, I. L., Bezborodova, O. A., Shmarov, M. M., Logunov, D. Y., Neugodova, G. L., Nemtsova, E. R., Naroditsky, B. S., Yakubovskaya, R. I., & Gintsburg, A. L. (2009). Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristics. Protein Expression and Purification, 65(1), 100\u2013107.","journal-title":"Protein Expression and Purification"},{"key":"4237_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1472-6750-7-17","volume":"7","author":"T Corral","year":"2007","unstructured":"Corral, T., Ver, L. S., Mottet, G., Cano, O., Garcia-Barreno, B., Calder, L. J., Skehel, J. J., Roux, L., & Melero, J. A. (2007). High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system. BMC Biotechnology, 7, 17.","journal-title":"BMC Biotechnology"},{"issue":"1","key":"4237_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1637\/11965-090118-Reg.1","volume":"63","author":"L Shi","year":"2019","unstructured":"Shi, L., Hu, Z., Hu, J., Liu, D., He, L., Liu, J., Gu, H., Gan, J., Wang, X., & Liu, X. (2019). Single immunization with Newcastle disease virus-vectored H7N9 Vaccine confers a complete protection against challenge with highly pathogenic avian influenza H7N9 virus. Avian Diseases, 63(1), 61\u201367.","journal-title":"Avian Diseases"},{"issue":"1","key":"4237_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/JVI.02380-14","volume":"89","author":"N Cuburu","year":"2015","unstructured":"Cuburu, N., Wang, K. N., Goodman, K. N., Pang, Y. Y., Thompson, C. D., Lowy, D. R., Cohen, J. I., & Schiller, J. T. (2015). Topical herpes simplex virus 2 (HSV-2) Vaccination with human papillomavirus vectors expressing gB\/gD ectodomains induces genital-tissue-resident memory CD8(+) T cells and reduces genital disease and viral shedding after HSV-2 challenge. Journal of Virolology, 89(1), 83\u201396.","journal-title":"Journal of Virolology"},{"issue":"1","key":"4237_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/vim.2016.0090","volume":"30","author":"MPD Zajac","year":"2017","unstructured":"Zajac, M. P. D., Zanetti, F. A., Esusy, M. S., Federico, C. R., Zabal, O., Valera, A. R., & Calamante, G. (2017). Induction of both local immune response in mice and protection in a rabbit model by intranasal immunization with modified vaccinia Ankara virus expressing a secreted form of bovine herpesvirus 1 glycoprotein D. Viral Immunology, 30(1), 70\u201376.","journal-title":"Viral Immunology"},{"issue":"5","key":"4237_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/intimm\/dxu107","volume":"27","author":"XY Zhan","year":"2015","unstructured":"Zhan, X. Y., Slobod, K. S., Jones, B. G., Sealy, R. E., Takimoto, T., Boyd, K., Surman, S., Russell, C. J., Portner, A., & Hurwitz, J. L. (2015). Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. International Immunology, 27(5), 229\u2013236.","journal-title":"International Immunology"},{"issue":"5","key":"4237_CR37","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/JVI.02036-10","volume":"85","author":"J Maamary","year":"2011","unstructured":"Maamary, J., Array, F., Gao, Q., Garcia-Sastre, A., Steinman, R. M., Palese, P., & Nchinda, G. (2011). Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice. Journal of Virolology, 85(5), 2235\u20132246.","journal-title":"Journal of Virolology"},{"issue":"4","key":"4237_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chembiol.2021.10.004","volume":"29","author":"A Bujotzek","year":"2022","unstructured":"Bujotzek, A., Tiefenthaler, G., Lariviere, L., D\u2019Andrea, L., Marquez, E. A., Rudloff, I., Cho, S. X., Deen, N. S., Richter, W., Regenass-Lechner, F., Poehler, A., Whisstock, J. C., Sydow-Andersen, J., Reiser, X., Schuster, S., Neubauer, J., Hoepfl, S., Richter, K., Nold, M. F., \u2026 Ellisdon, A. M. (2022). Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential. Cell Chemical Biology, 29(4), 586-596 e4.","journal-title":"Cell Chemical Biology"},{"issue":"1","key":"4237_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12951-022-01456-z","volume":"20","author":"X Hu","year":"2022","unstructured":"Hu, X., Fan, J., Ma, Q., Han, L., Cao, Z., Xu, C., Luan, J., Jing, G., Nan, Y., Wu, T., Zhang, Y., Wang, H., & Ju, D. (2022). A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease. Journal of Nanobiotechnology, 20(1), 237.","journal-title":"Journal of Nanobiotechnology"},{"key":"4237_CR40","doi-asserted-by":"publisher","first-page":"893648","DOI":"10.3389\/fimmu.2022.893648","volume":"13","author":"AI Schriek","year":"2022","unstructured":"Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W., & van Gils, M. J. (2022). Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate fc effector functions. Frontiers in Immunology, 13, 893648.","journal-title":"Frontiers in Immunology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-04237-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:42:13Z","timestamp":1684863733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-04237-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["4237"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-04237-4","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"8 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Jiangsu Administrative Committee for Laboratory Animals (Permission number: SYXK-SU-2007\u20130005), and complied with the guidelines of Jiangsu laboratory animal welfare and ethics of Jiangsu Administrative Committee of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}